Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has undergone significant changes, including the addition of new facility names and locations, as well as updates to medical terms related to plasma cell myeloma and various compounds. Notably, several previous terms and topics related to multiple myeloma and various pharmacological agents have been removed.SummaryDifference4%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.